Clinical Trial Update: Resveratrol in Treating Patients With Colorectal Cancer That Can Be Removed By Surgery [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating resveratrol for colorectal cancer that can be surgically removed has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer
• Rectal Cancer

Drugs mentioned

• Resveratrol (resveratrol)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum | Phase 1 | Status: COMPLETED